The global vials market was valued at $1,263.0 million in 2020, and it will progress at a CAGR of 8.6% between 2021 and 2030, as per the estimates of P&S Intelligence, a market research company based in India. The factors driving the expansion of the market are the soaring production capacity of vial manufacturing companies, surging healthcare expenditure, and booming pharmaceutical industry across the globe. The burgeoning requirement for vials for packaging COVID-19 vaccines is also fueling the market growth.

Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/vials-market-report/report-sample

The expansion of the pharmaceutical industry is one of the prominent factors propelling the growth of the market. Glass vial manufacturers such as Gerresheimer AG and SCHOTT AG have witnessed a sharp surge in the demand for vials from pharmaceutical companies, primarily for use in COVID-19 vaccine production processes. Moreover, many biotech and pharmaceutical companies are making huge investments for expanding their production capacities so that they can meet the worldwide demand for COVID-19 vaccines.

Make an Enquiry Before Purchase: https://www.psmarketresearch.com/send-enquiry?enquiry-url=vials-market-report

Globally, Europe held the largest share in the market in 2020, primarily because of the existence of several vial manufacturing companies in the region. On the other hand, in the upcoming years, the vials market will demonstrate the highest CAGR in the Asia-Pacific (APAC) region. This is ascribed to the fact that many companies operating in the industry are focusing on building new plants and augmenting their production capacities to bridge the supply and demand gap in the region.

Thus, it can be said with full surety that the market will exhibit huge expansion across the world in the coming years, mainly due to the increasing healthcare expenditure and expanding pharmaceutical industry in several countries.